Immunotherapy is here to stay: a new treatment paradigm in lung cancer

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Rocha, Pedro P.
  • dc.contributor.author Arriola Aperribay, Edurne
  • dc.date.accessioned 2019-03-05T08:15:43Z
  • dc.date.issued 2019
  • dc.format.mimetype application/pdf
  • dc.identifier.citation Rocha P, Arriola E. Immunotherapy is here to stay: a new treatment paradigm in lung cancer. Arch Bronconeumol.2019 Mar;55(3):124-125. DOI: 10.1016/j.arbres.2018.08.012
  • dc.identifier.doi http://dx.doi.org/10.1016/j.arbres.2018.08.012
  • dc.identifier.issn 0300-2896
  • dc.identifier.uri http://hdl.handle.net/10230/36736
  • dc.language.iso eng
  • dc.publisher Elsevier
  • dc.relation.ispartof Archivos de Bronconeumología. 2019 Mar;55(3):124-5
  • dc.rights © Elsevier http://dx.doi.org/10.1016/j.arbres.2018.08.012
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.subject.other Immunoteràpia
  • dc.subject.other Pulmons -- Càncer
  • dc.title Immunotherapy is here to stay: a new treatment paradigm in lung cancer
  • dc.type info:eu-repo/semantics/article
  • dc.type.version info:eu-repo/semantics/acceptedVersion